Elsevier

Microbes and Infection

Volume 22, Issue 10, November–December 2020, Pages 515-524
Microbes and Infection

Review
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system

https://doi.org/10.1016/j.micinf.2020.09.004Get rights and content
Under an Elsevier user license
open access

Abstract

This article discusses standard and new disruptive strategies in the race to develop an anti-COVID-19 vaccine. We also included new bioinformatic data from our group mapping immunodominant epitopes and structural analysis of the spike protein. Another innovative approach reviewed here is the use of BCG vaccine as priming strategy and/or delivery system expressing SARS-CoV-2 antigens.

Keywords

COVID-19
SARS-CoV-2
RBD domain
Vaccines
BCG

Cited by (0)